-
Cy5 NHS ester(Et): Labeling Workflow Guide
2026-09-07
Cy5 NHS ester(Et) is an amine-reactive fluorescent dye for covalently labeling proteins, peptides, and related biomolecules through primary amines. This guide covers practical protein fluorescent labeling, immunofluorescence staining, flow cytometry, and microscopy workflows, while defining why ethanol-based preparation and long-term storage of working solutions should be avoided.
-
Alternariol and LX-2 Fibrotic Transdifferentiation
2026-09-07
The reference study shows that Alternariol (AOH) and alternariol monomethyl ether, but not tenuazonic acid under the reported conditions, promote LX-2 hepatic stellate-cell transdifferentiation toward a contractile, extracellular-matrix-producing myofibroblast phenotype. By integrating lncRNA-mRNA omics with pathway and detoxification experiments, the work links Alternaria toxin exposure to NF-κB signaling, ferroptosis, autophagy-related responses, and a CotA laccase-based mitigation strategy.
-
IR-1061 Nanoparticles for Deep OTN-NIR Imaging
2026-09-05
The reference study developed PEG-modified polystyrene nanoparticles that encapsulate IR-1061 for emissive over-1000 nm near-infrared imaging. By matching nanoparticle polarity to the dye and optimizing the swelling–diffusion loading process, the authors obtained stable probes suitable for physiological testing and dynamic mouse imaging.
-
Medroxyprogesterone Acetate: A Systems Biology Lens
2026-09-04
Explore how Medroxyprogesterone acetate (MPA) can function as a context-sensitive probe of steroid signaling across renal, reproductive, and neural models. This article translates a recent multi-omics study of endometrial stromal cell senescence into practical assay-design decisions without conflating hyperoside findings with MPA biology.
-
FAST for Food-Grade Nutraceutical Nanoparticles
2026-09-04
The reference study presents Facilitated Self-Assembling Technology (FAST) as a food-grade, surfactant-free route for producing stable nanoparticles of poorly soluble nutraceuticals. Its findings suggest that spontaneous assembly, hybrid formulation, and cell-compatible fluorescence imaging can support scalable oral delivery research, while further pharmacokinetic and translational validation remains necessary.
-
Estradiol Benzoate: Assay Design Beyond Binding
2026-09-03
Estradiol Benzoate is an estrogen receptor alpha agonist suited to research spanning direct receptor binding and downstream transcriptional responses. This guide presents an assay-architecture framework that separates ligand affinity, receptor activation, and computational hypothesis generation.
-
LY-411575: From Aβ Biology to Notch-Immune Strategy
2026-09-03
LY-411575 offers a powerful way to connect amyloid precursor protein processing with Notch biology. This thought-leadership framework explains how to use the compound as a mechanistic and translational benchmark across Alzheimer’s disease research and cancer research while keeping pathway efficacy, exposure, and safety interpretation aligned.
-
EZ Cap™ Firefly Luciferase mRNA for Reliable Assays
2026-09-02
This scenario-based guide explains how EZ Cap™ Firefly Luciferase mRNA, SKU R1018, can improve reporter expression workflows for viability, cytotoxicity, translation, and imaging studies. It focuses on assay interpretation, RNA handling, transfection compatibility, and evidence-based product selection without overstating comparative performance.
-
Regorafenib Targets RRM2 in Melanoma
2026-09-02
The 2024 iScience study identifies RRM2 as a downstream mediator of Regorafenib activity in melanoma and connects its suppression to ERK/E2F3 signaling. Across cell-based and in vivo experiments, the work links reduced RRM2 with impaired melanoma growth, invasion, metastasis, and increased apoptosis, while also defining practical considerations for mechanistic cancer biology research.
-
Dabigatran Assays: Parent Drug vs Metabolite
2026-09-01
Dabigatran and Pradaxa are best understood through assay context, not concentration alone. This guide explains how parent drug, dabigatran acylglucuronide, thrombin-generation endpoints, and routine coagulation tests should shape experimental design.
-
Cy5 NHS ester(Et): Practical Labeling Guide
2026-09-01
Cy5 NHS ester(Et) is an amine-reactive fluorescent dye for covalently tagging proteins, peptides, and other biomolecules through primary amino groups. It is suited to aqueous or DMSO-based protein fluorescent labeling, immunofluorescence staining, flow cytometry, and fluorescence microscopy, but ethanol-based workflows and long-term storage of prepared solutions should be avoided.
-
4-Hydroxytamoxifen: Practical Workflow Guide
2026-08-31
4-Hydroxytamoxifen (SKU B6167) is a DMSO-compatible estrogen receptor modulator for controlled in vitro and in vivo research workflows, including breast cancer research, prostate cancer research, apoptosis assays, and cardiac myocyte calcium handling studies. It should not be selected for protocols requiring water- or ethanol-based preparation, and solution storage should be minimized.
-
EZ Cap™ Firefly Luciferase mRNA Workflow
2026-08-31
Build reproducible reporter assays and delivery screens with Cap1-capped, polyadenylated luciferase mRNA. This guide connects cell-based translation measurements with LNP formulation decisions and in vivo bioluminescence imaging.
-
Macrophage Assays with Cy5-Labeled mRNA
2026-08-30
EZ Cap™ Cy5 EGFP mRNA (5-moUTP) enables researchers to distinguish mRNA uptake from productive translation in difficult-to-transfect macrophages. This article translates nanoparticle targeting evidence into a practical dual-channel assay strategy for delivery optimization and gene function studies.
-
HFPO-DA Worsens Stroke via the CK2–NF-κB Axis
2026-08-29
Jia and colleagues show that HFPO-DA exposure aggravates ischemic brain injury in rats, with stronger neurological deficits, larger infarcts, and reactive microgliosis after MCAO/R. The study connects this environmental toxicant to a CSNK2A1/GSK3B/NF-κB signaling axis using computational, cellular, genetic, and pharmacological evidence.